Abeta 1-42 Antikörper

Produktnummer ABIN334634

Der Huhn Polyklonal anti-Abeta 1-42 Antikörper wird verwendet zum Nachweis von Abeta 1-42 in Proben von Human. Er wurde validiert für ELISA und DB.

Kurzübersicht für Abeta 1-42 Antikörper (ABIN334634)

Target: Abeta 1-42 (Amyloid beta 1-42 (Abeta 1-42))

Reaktivität: Human

Wirt: Huhn

Klonalität: Polyklonal

Konjugat: Dieser Abeta 1-42 Antikörper ist unkonjugiert

Applikation: ELISA, Dot Blot (DB)

Produktdetails anti-Abeta 1-42 Antikörper

Verwendungszweck: Anti-Abeta (1-42) | Amyloid-beta peptide 1-42

Kreuzreaktivität (Details): Human
Not reactive in: No confirmed exceptions from predicted reactivity are currently known

Homologie: Bovine,Chicken,Dog,Porcine,Rabbit

Aufreinigung: Purified total IgY

Immunogen: Synthetic peptide chosen from human Abeta (1-42) protein

Isotyp: IgY

Anwendungsinformationen

Applikationshinweise: 1 : 1000 (Dot), 1 : 500 (ELISA)

Kommentare:

the antibody can detect Abeta(1-42), but does not react with Abeta(1-40), Abeta(1-41), Abeta(1-28) Abeta(1-20) or Abeta(1-17)

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Purified total IgY (chicken egg yolk immunoglobulin) in PBS pH 8. Contains 0.02 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Please remember to spin the tubes briefly prior to opening them to avoid any losses that might occur from material adhering to the cap or sides of the tube

Lagerung: 4 °C

Informationen zur Lagerung: Store at 4°C, make aliquots to avoid working with a stock. Please remember to spin the tubes briefly prior to opening them to avoid any losses that might occur from material adhering to the cap or sides of the tube.

Details zu Abeta 1-42

Target: Abeta 1-42 (Amyloid beta 1-42 (Abeta 1-42))

Andere Bezeichnung: Amyloid-beta 42 protein (Abeta (1-42))

Hintergrund: Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in the growing population of elderly people. A hallmark of AD is the accumulation of plaques in the brain of AD patients. The plaques predominantly consist of aggregates of amyloid-beta (Abeta), a peptide of 39-42 amino acids generated in vivo by specific, proteolytic cleavage of the amyloid precursor protein P05067

Molekulargewicht: 4.5 kDa